Dr Nancy De Bremaeker
Dr Nancy De Bremaeker manages the regulatory and ethics submissions of Investigator Initiated Trials (IIT) in Luxembourg, Belgium and The Netherlands in various therapeutic areas including pediatry, rare diseases, oncology and neurology.
She coordinates the on-site performing monitors and is responsible for the overall project management of the trials at a country level.
She is also European correspondent for the academic clinical trials network (ECRIN) providing regulatory & ethics advice for IIT in Luxembourg and Belgium.
- TINN (Infectious disease, Neonatal Intensive Care Unit): Fluconazole versus Micafungin in neonates with suspected or culture-proven Candidiasis: a randomized pharmacokinetic and safety study
- RESCUE ESES (Neuropediatry, rare disease): Corticosteroids or clobazam for ESES syndrome: a European, multicenter, randomized, controlled clinical trial
- POEM (Surgery, rare disease): Endoscopic versus Laparoscopic Myotomy for Treatment of Idiopathic Achalasia: A Randomized, Controlled Trial
- EuroHYP (Neurology, Intensive Care Unit): European multicentre, randomised, phase III clinical trial of therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke